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Abstract 
BACKGROUND: The purpose of this research is to explore the existing natural resources in Jambi province 
which has potential as anti-dementia agent. So that will be many natural resources that can be a potential product 
in reducing the unwanted effects of dementia as a degenerative disorder that is currently an inevitable elderly 
disease. by investigating with various plants in Jambi that have activities as anti-dementia is expected more and 
more natural resources that can be used as neuron-protection and or neuron-curative. 
AIM: The purpose of this study is to find plants and / or compounds that are useful as neuroprotection 
METHODS: Dementia model is formed by diabetic test animals. The test group consisted of extract group, three 
fractions (hexane, ethyl acetate and butanol fraction at dose 500 mg/Kg BB p.o) and one group of antidiabetic 
drugs glibenclamide, and the group of normal animal test animals was tested with Radial arm maze (RAM) for 
seven days before alloxan induced to obtain dementia model. 
RESULTS: The results showed that extract and ethyl acetate fraction at dose 500 mg/Kg BW gave a positive 
effect on memory improvement based on animal performance on RAM tool during a testing time (P < 0, 05) with 
LSD statistical analysis. 
CONCLUSION: The extract and ethyl acetate fraction of Mikania micrantha showed good potential for improving 
the performance of animal memory in RAM devices representing dementia models. 
 
 
 
 
 
 
 
 
Introduction 
 
Dementia is a neurodegenerative disease that 
is linearly correlated with aging [1]. The incidence is 
reduced by age below 60 years. Dementia is 
characterized by a decrease in cognitive and 
behavioral function. Dementia is also a marker of 
progressive destruction of the brain's physiological 
function, Alzheimer's is one of the most frightening 
forms of dementia, hence numerous studies have 
been conducted both in vivo and in vitro to know more 
about the pathological path of dementia so that 
scientists can know how to prevent and treat the 
condition.  
Recent studies have shown a link between 
the incidence of diabetes mellitus (DM) [2], [3], [4] and 
an increased risk factor for the occurrence of 
dementia. Dementia in diabetic patients is associated 
with an impairment of brain insulin receptors leading 
to a decrease in cognitive function (learning and 
remembering) and behavioral alterations presumably 
caused by cerebral inflammation [5], [6], [7]. 
Cucumber plant (Mikania micrantha K), which 
is a plant of the genus Asteracea, which until now only 
42 species of plant families have been experiments on 
biological activity. Where the plant has anti-
inflammatory, analgesic, anti-bacterial, anti-protozoa, 
antioxidant and cytotoxic. Recent research also 
mentions that mikania micrantha cultivation can be 
used for depression conditions. Therefore, in this 
study, we will conduct an investigation of anti-
dementia activity test from mikania plant to animal 
model of diabetes mellitus which in induction alloxan. 
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Material and Methods 
 
Material 
Mikania micrantha, EtOH, Butanol, Ethyl 
Acetate, radial arm maze (RAM) [8] Gluco D®, rotary 
evaporator, analytic balance, alloxan, aquadest, 
glibenclamide. 
 
Animal 
The test animals used were white male mice 
of 2-3 months Mus musculus strain which was fed and 
drank well before testing of the test animal was fasted 
for 18 hours. 
 
Methods 
The dementia model was prepared by alloxan 
induction of 150 mg/kg i.p, in which all test animals 
showed a decreased cognitive ability to remember in 
the RAM test apparatus. During the acclimatization of 
the test animals, first use the cognition test tool using 
RAM [9], [8], [10].  The animal group was divided into 
6 test groups, comprising Positive group 
(glibenclamide), Negative group (alloxan induction) 
150 mg/Kg BW. 
The extracted group and 3 fractions (ethyl 
acetate, butane, and hexane) dose 500 mg/kg p.o 
given for 28 days. And observations of blood glucose 
and cognitive changes in the tool RAM performed on 
days 7, 14, 21 and 28 
 
 
Results  
 
Observations during the test period showed a 
decrease in the blood glucose of test animals showed 
in Table 1. 
Table 1: Glucose blood level 
Group 1 7 14 21 28 
Positive 142.2 ± 8.5 103.6 ± 5.4 104.2 ± 5.2 115 ± 4.4 99 ± 4.6 
Negative 383.8 ± 10.1 334.2 ± 12.7 279.6 ± 9.0 239.6 ± 10.3 240.2 ± 6.3 
Extract 241.4 ± 4.7 200.2 ± 3.2 176.6 ± 2.7 137.6 ± 7.9 133.8 ± 5.7 
f-ethyl acetate 234 ± 3.6 185.2 ± 3.6 161 ± 2.9 141 ± 7.4 123.8 ± 3.6 
f-butane 250.2 ± 4.7 208 ± 6.7 179.8 ± 4.2 156.8 ± 4.0 160.6 ± 7.0 
f-hexane 276 ± 6.8 220.6 ± 3.4 204.4 ± 3.9 186 ± 4.7 171.2 ± 3.0 
The results of decreased blood glucose of the test animals during the observation period showed 
that during the testing period the ethyl acetate fraction gave significant glucose decrease 
compared with the positive control (glibenclamide); All value is mean ± standard error (n = 6); 
Statistical analysis with LSD (*P < 0.05). 
 
Table 1 showed that From this study it is 
known that the use of alloxan as an inducer of blood 
glucose increase is quite good in showing the 
increase of blood glucose as a manifestation of type 2 
diabetes mellitus this is shown at the level of blood 
glucose in the negative group (alloxan induction) gives 
a significant increase in blood glucose up to the day to 
28. The test group using the mikania sp fraction which 
gave the best glucose reduction in the test animals 
was from the ethyl acetate fraction group. However, 
the decrease in glucose levels by ethyl acetate 
fraction has not been as good as the decrease of 
glucose level by glibenclamide group. 
The increase of blood glucose by induced by 
alloxan is good enough to provide a model of 
dementia in test animals where increased glucose in 
the blood leads to increased time required for test 
animals to complete their tests on the RAM device. 
Giving a fraction of the Mikania Sp plant from the ethyl 
acetate fraction provides a memory improvement 
performance which is indicated by the decrease of 
time required by the test animal completing its task on 
the RAM tool. This was demonstrated by no 
significant difference in the performance of test 
animals on RAM devices between ethyl acetate 
fraction groups and glibenclamide group be seen in 
the Table 2.  
Table 2: Retention Time on RAM 
Group 1 7 14 21 28 
Positive 297.2 ± 1.35 233.4 ± 1.7 190 ± 1.4 183 ± 1.0 171.8 ± 1.2 
Negative 600 ± 0 460.4 ± 2.3 429.8 ± 1.8 419.6 ± 0.9 402.8 ± 1.7 
Extract 288.2 ± 1.4 272.4 ± 1.8 217.8 ± 1.4 188.4 ± 1.3 169.4 ± 1.0 
f ethyl acetate 297 ± 1.7 244.4 ± 1.3 216.6 ± 1.3 195 ± 1.4 171 ± 1.7 
f-butanol 309.8 ± 1.3 265.4 ± 1.6 223.4 ± 1.6 203.4 ± 1.3 192.2 ± 1.3 
f-hexane 316.4 ± 1.1 306.6 ± 2.9 290.2 ± 1.4 241 ± 1.4 204.8 ± 1.2 
The results of retention time on RAM showed that during the testing period the ethyl acetate 
fraction gave significant decrease time on RAM compared with the positive control (glibenclamide); 
All value is mean ± standard error (n = 6); Statistical analysis with LSD (*P < 0.05). 
 
A similar thing is seen at the level of animal 
testing error when completing the task on the RAM 
tool. Groups of ethyl acetate fraction and Mikania 
extract Sp gave fewer mistakes similar to those given 
by the glibenclamide group. This was demonstrated 
by no significant difference in the performance of test 
animals on RAM devices between ethyl acetate 
fraction groups and glibenclamide group be seen in 
the Table 3. 
Table 3: Error Choice of RAM 
Group 1 7 14 21 28 
Positif 6.2 ± 0.2 3.4 ± 0.2 4 ± 0.4 2.6 ± 0.2 2.4 ± 0.2 
Negative 0 7.7 ± 0.5 7.8 ± 0.3 7.4 ± 0.5 7.2 ± 0.3 
Extract 6 ± 0.4 3.6 ± 0.2 3 ± 0.3 2.4 ± 0.3 2.2 ± 0.2 
f ethyl acetate 4.8 ± 0.3 4 ± 0.4 3.4 ± 0.2 3.2 ± 0.3 2.6 ± 0.4 
f-butanol 6.4 ± 0.5 4.4 ± 0.2 3.8 ± 0.3 3.4 ± 0.4 2.8 ± 0.3 
f-hexane 7.8 ± 0.3 4.6 ± 0.4 4 ± 0.3 3.8 ± 0.3 3 ± 0.4 
The results of Error choice on RAM showed that during the testing period the ethyl acetate fraction 
gave significant low error choice on RAM compared with the positive control (glibenclamide); All 
value is mean ± standard error (n = 6); Statistical analysis with LSD (*P <0.05). 
 
 
Discussion 
 
To see the impact of memory performance 
improvements on our RAM tools make animal models 
of dementia by using alloxan induction. in some 
previous journals have also mentioned that the rise in 
blood glucose, especially in diabetic patients believed 
to have a significant impact on the formation of 
dementia in correlation with cerebral vascular 
inflammation resulting in decreased cognitive abilities 
Herbal Medicine in Pharmaceutical and Clinical Sciences 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
3854  https://www.id-press.eu/mjms/index 
 
and behavioral changes of diabetic patients. cognitive 
decline, especially in the ability to learn and remember 
this is due to a decrease in sensitivity to insulin 
signals in the brain. vascular inflammatory conditions 
and beta-amyloid plaque formation are believed to be 
closely related to the progress of the severity of 
Alzheimer's disease [2], [3], [11]. 
In this study showed that dementia animal 
model can be generated by alloxan induction, in which 
the increase of blood glucose in animal test resulted in 
the decrease of blood glucose level from all animal 
group of tests and decrease of blood glucose seen 
significantly in ethyl acetate group compared with 
group glibenclamide as a positive group. compound 
compounds in plants that have anti-diabetic activity 
are believed to be from terpenoid group compounds 
that can reduce the damaging effects of excessive 
oxidation on pancreatic beta cells in this case as a 
result of alloxan induction. as a result of decreased 
oxidation reaction by this terpenoid, group compound 
showed improvement of blood glucose levels. the in 
vivo study of the Mikania micrantha plant showed that 
this plant had 13 identifiable sesquiterpen lactones 
compounds. micrantholides are thought to have 
excellent anti-inflammatory properties. triterpenes and 
phytosterols are known to be widespread in plants 
from the Mikania family [12], [13], [14]. 
Improvements in memory performance in 
RAM assayers showed significance in the ethyl 
acetate group of animals compared with the negative 
group and positive group by decreasing retention time 
and many faults from the test animals to find their food 
in the RAM device. when compared with the positive 
test animal group (glibenclamide), the ethyl acetate 
assay group gave significant improvement in memory 
performance in follow-up with the extract group. this 
reinforces the notion that the chemical compounds of 
the mikania plant of the ethyl acetate fraction have 
activity against the memory improvement of the test 
animals. Because the dementia model derived from 
alloxan induction this can reinforce the theory that 
diabetes is a risk factor of the incidence of dementia. 
Dementia as a pointer to the progressive destruction 
of nerve cell cells where the worst effects of dementia 
conditions are Alzheimer's disease that remains 
unaccounted for. however, the memory repair 
mechanism of the Mikania micrantha compound on 
memory improvement is still unclear, whether this 
memory repair works directly on the improvement of 
insulin signaling in the brain that will inhibit 
inflammation in the brain that can improve cognitive 
performance [2], [15], [13], [4] animal approach of this 
animal model of diabetes can be used as a 
preliminary study in studying the course of the disease 
from dementia. from the results obtained further 
research led the researcher to be able to continue to 
elude other dementia models to find a suitable 
mechanism to explain the pathological condition of 
dementia in order to lead to the discovery of 
compounds that can be used as neuro-protection and 
neuro-curative useful for further treatment [16], [17], 
[18], [8], [19]. 
In conclusion from the results of this study 
showed that Mikania micrantha has a positive activity 
on the central nervous system and can be used as an 
alternative plant as neuro-protection and neuro-
curative. 
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